CSL News & Analysis
How our analyst views the shares after the clinical trial set-back.
Shane Ponraj | 12 February 2024
Stock markets are highly efficient in the long run yet share prices can fluctuate wildly near term. The art of investing is buying quality stocks...
James Gruber | 23 November 2023
Thomas Rowe Price Jnr shocked Wall Street in the mid-60s by presciently selling growth stocks and buying real assets. His warnings to growth...
James Gruber | 14 September 2023
Schroders' Australian equity team say investors piling into tech stocks again are ignoring a turning point in markets.
James Gruber | 06 September 2023
And what do our analysts think of the stocks?
Shani Jayamanne | 04 September 2023
Aligning a share to your investment strategy is the key to investing successfully. This ASX share with a moat is finally trading at an attractive...
Mark LaMonica, CFA | 28 August 2023
CSL’s share price reacted positively to results but our analyst is looking at the long-term prospects.
Morningstar | 16 August 2023
Shares in this well-known ASX20 stock have tumbled in recent weeks, but is the market selloff overdone?
Joshua Peach | 11 July 2023
What do our analysts think about Morningstar Investor subscriber's top trades in June so far?
Shani Jayamanne | 26 June 2023
Shares in the ASX giant were sold off on Wednesday as currency headwinds weigh on CSL's near-term margin recovery, but we believe the long-term...
Shane Ponraj | 14 June 2023
Viewing 1 to 10 of 48